Crispina Calsada - Jan 18, 2024 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Chief Financial Officer
Signature
Christopher Aker, Attorney in Fact
Stock symbol
RGLS
Transactions as of
Jan 18, 2024
Transactions value $
-$6,510
Form type
4
Date filed
1/18/2024, 08:24 PM
Previous filing
Jan 17, 2024
Next filing
May 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Sale -$6.51K -5.47K -48.6% $1.19 5.78K Jan 18, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares of common stock to cover tax withholding obligations incurred in connection with the vesting of the restricted stock unit award received by the Reporting Person on 1/11/2023.